Literature DB >> 2400984

Comparison of DNA aneuploidy of primary and metastatic spontaneous canine osteosarcomas.

M H Fox1, L W Armstrong, S J Withrow, B E Powers, S M LaRue, R C Straw, E L Gillette.   

Abstract

Spontaneous canine osteosarcomas were analyzed for DNA aneuploidy and percentage of S phase cells using flow cytometry. Forty-eight dogs were studied in which both a primary tumor and subsequent metastases were available. The DNA index distributions for the primary tumors and the metastases were quite similar. However, when individual primary tumors and metastases derived from them were compared, many of the cases had different ploidy values. The tumor cells were also analyzed for percentage of S phase. The diploid metastases had less than 17% S phase cells, whereas the aneuploid metastases had up to 40% S phase cells. There was a direct correlation between the DNA index and the percentage of S phase in the metastases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400984

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs.

Authors:  M Król; J Polańska; K M Pawłowski; P Turowski; J Skierski; A Majewska; M Ugorski; R E Morty; T Motyl
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

2.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

3.  Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomas.

Authors:  L C Wijnaendts; J C van der Linden; P van Diest; A J van Unnik; J F Delemarre; P A Voûte; C J Meijer
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

4.  Nuclear DNA-Content in Mesenchymal Lesions in Dogs: Its Value as Marker of Malignancy and Extent of Genomic Instability.

Authors:  Kim M Boerkamp; Gerard R Rutteman; Marja J L Kik; Jolle Kirpensteijn; Christoph Schulze; Guy C M Grinwis
Journal:  Cancers (Basel)       Date:  2012-12-03       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.